128 evolution "https:" "https:" "https:" "https:" "https:" "https:" "University of Minho" "EURAXESS" uni jobs at King's College London
Sort by
Refine Your Search
-
development at all levels in alignment with School priorities. A commitment to nurturing talent is essential, including the supervision and mentoring of PhD students and early‑career researchers. Applicants
-
. Deliver performance management processes, including appraisals, training, and development planning. Foster a positive team culture built on trust, respect, and collaboration. Act as a key contact for
-
Transition & Outcomes Department, contributing to the development and delivery of a portfolio of student leadership, partnership and student success initiatives aligned with institutional strategic priorities
-
-based studies into early life development. This is a participant-facing role spanning perinatology and paediatrics, where you will manage a diverse mix of clinical, non-clinical, and administrative
-
) for professional development. This entitlement, from the Concordat to Support the Career Development of Researchers, applies to Postdocs, Research Assistants, Research and Teaching Technicians, Teaching Fellows and
-
. Experience of working with complex material to write accessible promotional copy 2. Experience in line management and staff development 3. Experience of working with audio-visual teams, to brief
-
(Projects) within the Early Career Researcher Institute, you will play a vital role in delivering high‑quality learning, development and support activities that empower Imperial’s early career researchers
-
: The Build Director will oversee the design, development and implementation of software applications within the university. This role is crucial in ensuring that the University's applications support Student
-
31st May 2027 with a possibility of an extension. Research staff at King’s are entitled to at least 10 days per year (pro-rata) for professional development. This entitlement, from the Concordat
-
for helping to continue the successful delivery and future development of ongoing epilepsy research projects funded by the UK Epilepsy Research Institute, Medical Research Council and Angelini Pharma